2016: advances in medical oncology


DOI:  https://www.doi.org/10.31917/1801115

Over the last year, there has been a wave of new successes with immunotherapy. Cancer therapies are becoming increasingly precise, thereby enabling a more personalized approach to treatment selection. To address the challenge of medical resistance, researchers have been developing more potent target, next-generation drugs. New chemotherapeutic options are appearedin clinical practice. It is result in changing of the treatment guidelines and significantincreasing of the overall survival.